Company says it is building a nationwide AI diagnostic infrastructure for brain diseases
JLK will supply AI solutions to 65 percent of the sites covered under a government-led public medical AI project.
The company said Monday it had been selected as the AI solution provider for 11 of the 17 major regional hub hospitals designated under the program.
The Ministry of Health and Welfare is investing 14.2 billion won (about $9.34 million) in the "Regional Responsible Medical Institution AI-Based Care System Support Project." The project aims to strengthen essential and public healthcare capacity and narrow medical gaps between regions by introducing AI-powered care systems.
JLK secured supply rights for 11 of the 17 institutions covered by the project, or 64.7 percent of the total. The company will provide a range of AI solutions and platforms supporting the diagnosis and analysis of stroke and other brain diseases.
The lineup includes JLK-CTP, a CT perfusion imaging analysis solution recently designated for exemption from new medical technology assessment, and JLK-LVO, which automatically detects large vessel occlusion in CTA images. Both tools are designed to help clinicians more quickly determine whether emergency stroke patients are eligible for treatment and whether interventional procedures are needed.
JLK is currently building out a suite of AI solutions covering the full spectrum of brain diseases, including cerebral hemorrhage, large vessel occlusion, cerebral infarction, cerebral aneurysm and white matter degeneration.
"This project will serve as a springboard to expand our real-world user base centered on regional responsible medical institutions nationwide," the company said. "We will accelerate commercialization in the public healthcare sector alongside our entry into the non-reimbursed market."
freiheit@heraldcorp.com
